Featured Jobs
|
Nova 401(k) Associates
|
|
Daybright Financial
|
|
Stones River Consulting
|
|
Relationship Manager – Defined Contributions Daybright Financial
|
|
Director, Strategic Accounts and Channel Development July Business Services
|
|
EPIC RPS
|
|
Director of Regulatory Operations and Compliance PCS Retirement
|
|
Regional Sales Director-Mid Atlantic July Business Services
|
|
Experienced Employee Benefits Attorney Shipman & Goodwin LLP
|
|
Internal Channel Sales Team Lead July Business Services
|
|
EPIC RPS
|
|
Independent Retirement
|
|
Spectrum Pension Consultants (part of Daybright Financial)
|
|
Daybright Financial
|
|
Regional Sales Director-Heartland July Business Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
SEC Provides No-Action Relief on Regulation BTR
Dodd-Frank.com, a blog by Leonard, Street and Deinard 
May 22, 2013 "Pfizer argued that the exchange offer would not result in inequitable treatment for those employees subject to a suspension, and hence Regulation BTR should not apply. In other words, this is not Enron. It's why Regulation BTR includes an exception for mergers etc., which should apply here, even if Rule 101(c)(9) does not specifically refer to exchange offers. The SEC granted the no-action request, subject to some conditions." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |